Form D · Other Health Care
UE LifeSciences Inc.
Philadelphia, PA · CIK 0001683096
Offering snapshot reported Nov 24, 2021 · SEC filing
- Reported sold
- $480K Offering amount: $5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 11, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 24, 2021 | Initial | $480,308 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-422328
Source: Form D, filed Nov 24, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ari Brooks | Director |
| Matthew Campisi | Executive, Promoter |
| Suren Gulrajani | Director |
| Bhaumik Sanghvi | Executive, Promoter |
| Mihir Shah | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3401 Market Street, Suite 200
Philadelphia, PA, 19104
Philadelphia, PA, 19104